The reverse split aims to boost the stock price above $1 to maintain Nasdaq listing. Monitor post-split trading to see if the price holds above $1; failure to sustain compliance could lead to delisting proceedings.
Price Chart
Executive Summary
BioRestorative Therapies announced a 1-for-20 reverse stock split effective Sept 7, 2026, to regain compliance with Nasdaq's $1 minimum bid price. The split reduces outstanding shares from ~27.6M to ~1.4M and proportionally reduces authorized shares. This is a routine compliance measure for a small-cap clinical-stage biotech trading below $1.
Key Facts
- 1-for-20 reverse stock split effective Sept 7, 2026
- Outstanding shares reduced from 27,622,556 to approximately 1,381,128
- Authorized shares reduced from 1.5B to 75M
- Purpose: regain compliance with Nasdaq $1 minimum bid price
- No stockholder approval required under Nevada law
Financial Impact
Reverse stock split reduces share count by 95% with no change to market capitalization; proportional adjustments to options and warrants.
Risk Factors
- Stock price may decline after split and fail to maintain $1 minimum bid
- Potential delisting if compliance not regained
- Reduced liquidity due to lower share count
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3355556 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $1.75 | awaiting T+20 | — | $1.58 (−9.71%) |
Sep 11, 2026 6w ago | 8-K | $2.67 $1.91 | ▲ +28.46% | ▲ +30.33% | $1.58 (+40.82%) |
Sep 2, 2026 7w ago | Press Release | $0.1437 $2.14 | ▲ +1389.21% | ▲ +1389.67% | $1.58 (+999.51%) |
Aug 25, 2026 8w ago | 8-K | $0.2169 $2.51 | ▼ −1057.22% | ▼ −1057.07% | $1.58 (−628.45%) |
Jun 12, 2026 19w ago | 8-K | $0.3910 $0.3400 | ▲ +13.04% | ▲ +13.04% | $1.58 (−304.09%) |
May 29, 2026 21w ago | 8-K | $0.4064 $0.3760 | ▲ +7.48% | ▲ +6.18% | $1.58 (−288.78%) |
May 1, 2026 25w ago | 8-K | $0.2420 $0.4064 | ▲ +67.93% | ▲ +62.29% | $1.58 (+552.89%) |
Apr 7, 2026 29w ago | Press Release | $0.2507 $0.2420 | ▼ −3.47% | ▼ −13.25% | $1.58 (+530.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers